
Annalise.ai is a leading health tech firm that leverages artificial intelligence (AI) to revolutionise medical imaging.
Annalise.ai is on a mission to elevate the standard of healthcare for millions of patients every day. By employing AI technologies in medical imaging, the company aims to enhance diagnosis and treatment, revolutionizing patient care and the practice of medicine. Founded as a joint venture between I-MED, Australia's largest diagnostic chain and Harrison.ai Annalise.ai has emerged as one of the largest players in the industry. The company's AI solutions* are cleared by the FDA, TGA, and CE, ensuring their adherence to rigorous quality and safety standards.
Headquarters
:
Bangalore, Karnataka, India
Business Model
:
Founding Date
:
2019
No. of Employees
:
151 to 250
Core Team
:
2019
Aug | Company Incorporation
2019: Company Inception.
2022
Jul | Key Leadership Hire
Annalise.ai appointed Lakshmi Gudapakkam to the role of CEO and Dr Rick Abramson to that of Chief Medical Officer
B2B
Annalise.ai's solutions are designed to cater to healthcare systems globally. They are suitable for primary, secondary, and tertiary healthcare centers, oncology and radiology departments, diagnostic chains, and teleradiology service providers.
Frequently Asked Questions